India Antimalarial Drugs Market to Grow with a CAGR of 4.26% through 2030

Increasing Healthcare Expenditure and Awareness and Education Campaigns are expected to drive the India Antimalarial Drugs Market growth in the forecast period, 2026-2030

According to TechSci Research report, “India Antimalarial Drugs Market – By Region, Competition, Forecast and Opportunities, 2030F”, the India Antimalarial Drugs Market stood at USD 30.15 million in 2024 and is anticipated to grow with a CAGR of 4.26% in the forecast period through 2030.

Advancements in diagnostic technologies, such as rapid diagnostic tests (RDTs) and molecular diagnostics, enable quicker and more accurate detection of malaria parasites. This facilitates timely treatment initiation, ensuring appropriate use of antimalarial drugs and improving patient outcomes. Research and development in pharmaceutical technology lead to the discovery and development of new antimalarial drugs and formulations. These innovations often enhance efficacy, reduce side effects, and address drug resistance issues, expanding the treatment options available in the market. Digital health platforms facilitate remote consultations, telemedicine services, and mobile health applications. These technologies improve access to healthcare in remote and underserved areas, allowing for timely prescription and delivery of antimalarial drugs.

Utilization of big data analytics and geographical information systems (GIS) aids in malaria surveillance and epidemiological mapping. This data-driven approach helps in identifying high-risk areas, predicting outbreaks, and optimizing resource allocation for antimalarial drugs distribution and intervention strategies. Integration of technology in supply chain management systems enhances the efficiency and transparency of drug procurement, storage, and distribution processes. This ensures a reliable supply of antimalarial drugs to healthcare facilities, minimizing stock-outs and ensuring continuous availability. Digital tools, such as mobile applications and wearable devices, support patient monitoring and adherence to treatment regimens. These technologies provide reminders for medication intake, track treatment progress, and facilitate communication between patients and healthcare providers, improving treatment outcomes. Advancements in genomics and vaccine development contribute to long-term malaria control efforts. Research into genetic markers of drug resistance and vaccine candidates aims to develop more targeted therapies and preventive measures, potentially reducing the reliance on antimalarial drugs in the future.

Technological solutions aid in maintaining regulatory compliance and ensuring the quality of antimalarial drugs. Digital systems for batch tracking, temperature monitoring during transport, and real-time quality control assessments contribute to product safety and efficacy. Technological advancements drive growth in the India Antimalarial Drugs Market by enhancing diagnostic capabilities, expanding treatment options, improving access to healthcare services, optimizing supply chain management, facilitating patient monitoring and adherence, supporting research and vaccine development, and ensuring regulatory compliance. These innovations contribute to more effective malaria control strategies, better patient outcomes, and overall market expansion in India's healthcare landscape.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on " India Antimalarial Drugs Market”

India Antimalarial Drugs Market is segmented into drug class, mechanism of action, distribution channel, regional distribution, and company.

Based on distribution channel, the hospital pharmacy segment has emerged as the predominant market leader, Located within or near healthcare facilities, hospital pharmacies ensure convenient access to antimalarial drugs for patients undergoing treatment in hospitals, particularly in emergency situations requiring immediate and intensive care. Staffed by qualified healthcare professionals, hospital pharmacies offer expertise in diagnosing and prescribing antimalarial medications based on clinical assessments and diagnostic findings. They provide a wide range of antimalarial drugs, including specialized formulations and combination therapies tailored to meet individual patient needs and treatment protocols. Hospital pharmacies adhere to strict quality control measures and regulatory standards to ensure the authenticity, efficacy, and safety of antimalarial drugs dispensed to patients. They maintain robust inventory management systems and conduct regular audits to prevent stockouts and manage medication expiration effectively. Integral parts of comprehensive healthcare systems, hospital pharmacies collaborate closely with medical teams to ensure coordinated and holistic management of malaria cases. They provide supportive care services such as patient education, counseling on medication use, and monitoring for adverse effects, thereby enhancing treatment adherence and optimizing therapeutic outcomes.

Major companies operating in India Antimalarial Drugs Market are:

• Cipla Ltd
• Sun Pharmaceutical Industries Ltd
• Glenmark Pharmaceuticals Ltd
• Strides Pharma Science Ltd
• Ipca Laboratories Ltd
• Aurobindo Pharma Ltd
• Alkem Laboratories Ltd
• Novartis India Ltd
• Lupin Limited
• Cadila Healthcare Ltd

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Growing collaboration between government agencies, pharmaceutical companies, international organizations, and non-profit entities. These partnerships foster joint investments in healthcare infrastructure, drug supply chains, and community outreach programs. Increased funding and resource pooling enhance the scalability and sustainability of malaria control efforts. Initiatives like vaccine development, capacity building, and policy advocacy strengthen the overall ecosystem for combating malaria in India”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“India Antimalarial Drugs Market, By Drug Class (Aryl aminoalcohol compounds, Antifolate compounds, Artemisinin compounds, Others), By Mechanism of Action (Treatment for Malaria, Prevention from Malaria), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of India Antimalarial Drugs Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Antimalarial Drugs Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com